These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 24092448)
1. Serum omentin levels in patients with obstructive sleep apnea. Kurt OK; Tosun M; Alcelik A; Yilmaz B; Talay F Sleep Breath; 2014 May; 18(2):391-5. PubMed ID: 24092448 [TBL] [Abstract][Full Text] [Related]
2. Association between continuous positive airway pressure and circulating omentin levels in patients with obstructive sleep apnoea. Uygur F; Tanrıverdi H; Can M; Erboy F; Altınsoy B; Atalay F; Ornek T; Damar M; Kokturk F; Tor M Sleep Breath; 2016 Sep; 20(3):939-45. PubMed ID: 26810494 [TBL] [Abstract][Full Text] [Related]
3. Melatonin and omentin: influence factors in the obstructive sleep apnoea syndrome? Zirlik S; Hildner KM; Targosz A; Neurath MF; Fuchs FS; Brzozowski T; Konturek PC J Physiol Pharmacol; 2013 Jun; 64(3):353-60. PubMed ID: 23959732 [TBL] [Abstract][Full Text] [Related]
4. Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome. Wang Q; Feng X; Zhou C; Li P; Kang J Ann Clin Biochem; 2013 May; 50(Pt 3):230-5. PubMed ID: 23605136 [TBL] [Abstract][Full Text] [Related]
5. Adiponectin, Omentin, Ghrelin, and Visfatin Levels in Obese Patients with Severe Obstructive Sleep Apnea. Zhang DM; Pang XL; Huang R; Gong FY; Zhong X; Xiao Y Biomed Res Int; 2018; 2018():3410135. PubMed ID: 30151379 [TBL] [Abstract][Full Text] [Related]
6. Serum cardiotrophin-1 and IL-6 levels in patients with obstructive sleep apnea syndrome. Kurt OK; Tosun M; Talay F Inflammation; 2013 Dec; 36(6):1344-7. PubMed ID: 23783568 [TBL] [Abstract][Full Text] [Related]
7. Effects of different obesity-related adipokines on the occurrence of obstructive sleep apnea. Xu X; Xu J Endocr J; 2020 May; 67(5):485-500. PubMed ID: 32307359 [TBL] [Abstract][Full Text] [Related]
8. Relationship between hepcidin levels and periodic limb movement disorder in patients with obstructive sleep apnea syndrome. Abakay O; Abakay A; Palanci Y; Yuksel H; Selimoglu Sen H; Evliyaoglu O; Tanrikulu AC Sleep Breath; 2015 May; 19(2):459-66. PubMed ID: 25008988 [TBL] [Abstract][Full Text] [Related]
9. The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Guven SF; Turkkani MH; Ciftci B; Ciftci TU; Erdogan Y Sleep Breath; 2012 Mar; 16(1):217-21. PubMed ID: 21331508 [TBL] [Abstract][Full Text] [Related]
10. Relationship between surfactant proteins B and C and obstructive sleep apnea: is serum SP-B concentration a potential biomarker of obstructive sleep apnea? Shao L; Li N; Yao X; Heizati M; Abdireim A; Wang Y; Abulikemu Z; Zhang D; Chang G; Zhou L; Hong J; Zhang Y; Kong J; Zhang X Sleep Breath; 2016 Mar; 20(1):25-31. PubMed ID: 25953386 [TBL] [Abstract][Full Text] [Related]
11. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sánchez-de-la-Torre M; Mediano O; Barceló A; Piérola J; de la Peña M; Esquinas C; Miro A; Durán-Cantolla J; Agustí AG; Capote F; Marin JM; Montserrat JM; García-Río F; Barbé F Sleep Breath; 2012 Sep; 16(3):649-56. PubMed ID: 21912907 [TBL] [Abstract][Full Text] [Related]
12. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer. Shen XD; Zhang L; Che H; Zhang YY; Yang C; Zhou J; Liang CZ Cytokine; 2016 Jan; 77():50-5. PubMed ID: 26539805 [TBL] [Abstract][Full Text] [Related]
13. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome? Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of omentin in end-stage renal disease patients. Alcelik A; Tosun M; Ozlu MF; Eroglu M; Aktas G; Kemahli E; Savli H; Yazici M Kidney Blood Press Res; 2012; 35(6):511-6. PubMed ID: 22813935 [TBL] [Abstract][Full Text] [Related]
15. High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis. Saely CH; Leiherer A; Muendlein A; Vonbank A; Rein P; Geiger K; Malin C; Drexel H Atherosclerosis; 2016 Jan; 244():38-43. PubMed ID: 26590865 [TBL] [Abstract][Full Text] [Related]
16. Catestatin serum levels are increased in male patients with obstructive sleep apnea. Borovac JA; Dogas Z; Supe-Domic D; Galic T; Bozic J Sleep Breath; 2019 Jun; 23(2):473-481. PubMed ID: 30088239 [TBL] [Abstract][Full Text] [Related]
17. Is obstructive sleep apnea syndrome a risk factor for pulmonary thromboembolism? Kezban OS; Ali NA; Umran T; Talha D; Ege GB; Peri A; Leyla YA; Hasan S Chin Med J (Engl); 2012 Oct; 125(20):3712-8. PubMed ID: 23075730 [TBL] [Abstract][Full Text] [Related]
18. Can we use serum copeptin levels as a biomarker in obstructive sleep apnea syndrome? Selcuk OT; Eyigor M; Renda L; Osma U; Eyigor H; Selcuk NT; Yılmaz MD; Demirkıran C; Unlu H; Gültekin M J Craniomaxillofac Surg; 2015 Jul; 43(6):879-82. PubMed ID: 25957103 [TBL] [Abstract][Full Text] [Related]
19. Serum omentin level in patients with prostate cancer. Uyeturk U; Sarıcı H; Kın Tekce B; Eroglu M; Kemahlı E; Uyeturk U; Gucuk A Med Oncol; 2014 Apr; 31(4):923. PubMed ID: 24659266 [TBL] [Abstract][Full Text] [Related]
20. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk. Hayashi M; Morioka T; Hatamori M; Kakutani Y; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M Diabetes Res Clin Pract; 2019 Feb; 148():160-168. PubMed ID: 30641171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]